Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

727 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ :  CD8+ ratio.
Hughes RA, May MT, Tilling K, Taylor N, Wittkop L, Reiss P, Gill J, Schommers P, Costagliola D, Guest JL, Lima VD, d'Arminio Monforte A, Smith C, Cavassini M, Saag M, Castilho JL, Sterne JAC. Hughes RA, et al. Among authors: costagliola d, d arminio monforte a. AIDS. 2018 Jun 19;32(10):1361-1367. doi: 10.1097/QAD.0000000000001848. AIDS. 2018. PMID: 29851663 Free PMC article.
Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups.
Phillips AN, Grabar S, Tassie JM, Costagliola D, Lundgren JD, Egger M. Phillips AN, et al. Among authors: costagliola d. AIDS. 1999 Oct 22;13(15):2075-82. doi: 10.1097/00002030-199910220-00010. AIDS. 1999. PMID: 10546860
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
Salmon-Céron D, Mazeron MC, Chaput S, Boukli N, Senechal B, Houhou N, Katlama C, Matheron S, Fillet AM, Gozlan J, Leport C, Jeantils V, Freymuth F, Costagliola D. Salmon-Céron D, et al. Among authors: costagliola d. AIDS. 2000 May 26;14(8):1041-9. doi: 10.1097/00002030-200005260-00017. AIDS. 2000. PMID: 10853987 Clinical Trial.
'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study.
Duran S, Solas C, Spire B, Carrieri MP, Fuzibet JG, Costagliola D, Lacarelle B, Moatti JP; Cohort Manif 2000 Study Group. Duran S, et al. Among authors: costagliola d. AIDS. 2001 May 25;15(8):1075-7. doi: 10.1097/00002030-200105250-00024. AIDS. 2001. PMID: 11399998 Clinical Trial. No abstract available.
Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.
Meynard JL, Vray M, Morand-Joubert L, Race E, Descamps D, Peytavin G, Matheron S, Lamotte C, Guiramand S, Costagliola D, Brun-Vézinet F, Clavel F, Girard PM; Narval Trial Group. Meynard JL, et al. Among authors: costagliola d. AIDS. 2002 Mar 29;16(5):727-36. doi: 10.1097/00002030-200203290-00008. AIDS. 2002. PMID: 11964529 Clinical Trial.
727 results